Comment:

This is collecting a bunch of pieces of knowedge, each of which should be an independent statement with its own status. Interactions, side effects, indications are all "knowledge" statements that might be made asserted by some domain expert with an assertion of level of evidence, authority source, etc. And such statements can be made about a variety of therapies and interventions. This needs to be decomposed (and perhaps collapsed into a single knowledge resource) with discussion with the CDS work group. Having a collection resource like this with this level of specificity is not viable for FHIR.

Summary:

Split MedicinalProductClinicals